These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2975904)

  • 21. Induction of a chemoattractive proinflammatory cytokine response after stimulation of keratinocytes with Propionibacterium acnes and coproporphyrin III.
    Schaller M; Loewenstein M; Borelli C; Jacob K; Vogeser M; Burgdorf WH; Plewig G
    Br J Dermatol; 2005 Jul; 153(1):66-71. PubMed ID: 16029328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammation in acne vulgaris.
    Webster GF
    J Am Acad Dermatol; 1995 Aug; 33(2 Pt 1):247-53. PubMed ID: 7622652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular immunity to P. acnes in the normal population and patients with acne vulgaris.
    Gowland G; Ward RM; Holland KT; Cunliffe WJ
    Br J Dermatol; 1978 Jul; 99(1):43-7. PubMed ID: 150284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resolution of inflammatory acne vulgaris may involve regulation of CD4+ T-cell responses to Propionibacterium acnes.
    Wilcox HE; Farrar MD; Cunliffe WJ; Holland KT; Ingham E
    Br J Dermatol; 2007 Mar; 156(3):460-5. PubMed ID: 17300234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease.
    Sugisaki H; Yamanaka K; Kakeda M; Kitagawa H; Tanaka K; Watanabe K; Gabazza EC; Kurokawa I; Mizutani H
    J Dermatol Sci; 2009 Jul; 55(1):47-52. PubMed ID: 19375895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis of acne vulgaris: recent advances.
    Bhambri S; Del Rosso JQ; Bhambri A
    J Drugs Dermatol; 2009 Jul; 8(7):615-8. PubMed ID: 19588637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgG subclasses specific to Staphylococcus epidermidis and Propionibacterium acnes in patients with acne vulgaris.
    Ashbee HR; Muir SR; Cunliffe WJ; Ingham E
    Br J Dermatol; 1997 May; 136(5):730-3. PubMed ID: 9205507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acne vaccines targeting Propionibacterium acnes.
    Kao M; Huang CM
    G Ital Dermatol Venereol; 2009 Dec; 144(6):639-43. PubMed ID: 19907403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The chemoattractant properties of comedonal components.
    Puhvel SM; Sakamoto M
    J Invest Dermatol; 1978 Nov; 71(5):324-9. PubMed ID: 152335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteomic and transcriptomic investigation of acne vulgaris microcystic and papular lesions: Insights in the understanding of its pathophysiology.
    Quanico J; Gimeno JP; Nadal-Wollbold F; Casas C; Alvarez-Georges S; Redoulès D; Schmitt AM; Fournier I; Salzet M
    Biochim Biophys Acta Gen Subj; 2017 Mar; 1861(3):652-663. PubMed ID: 27789243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different pro-inflammatory and immunogenic potentials of Propionibacterium acnes and Staphylococcus epidermidis: implications for chronic inflammatory acne.
    Białecka A; Mak M; Biedroń R; Bobek M; Kasprowicz A; Marcinkiewicz J
    Arch Immunol Ther Exp (Warsz); 2005; 53(1):79-85. PubMed ID: 15761379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxic activity of Propionibacterium acnes and other skin organisms.
    Allaker RP; Greenman J; Osborne RH; Gowers JI
    Br J Dermatol; 1985 Aug; 113(2):229-35. PubMed ID: 3161535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Propionibacterium acnes and inflammation in acne; P. acnes has T-cell mitogenic activity.
    Jappe U; Ingham E; Henwood J; Holland KT
    Br J Dermatol; 2002 Feb; 146(2):202-9. PubMed ID: 11903228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-vitro investigation of anti-acne properties of Mangifera indica L. kernel extract and its mechanism of action against Propionibacterium acnes.
    Poomanee W; Chaiyana W; Mueller M; Viernstein H; Khunkitti W; Leelapornpisid P
    Anaerobe; 2018 Aug; 52():64-74. PubMed ID: 29906773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous visualization of Propionibacterium acnes and Propionibacterium granulosum with immunofluorescence and fluorescence in situ hybridization.
    Jahns AC; Oprica C; Vassilaki I; Golovleva I; Palmer RH; Alexeyev OA
    Anaerobe; 2013 Oct; 23():48-54. PubMed ID: 23896347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cytotoxicity in acne vulgaris].
    Vignale RA; Espasandín J; Lasalvia E; Borras A
    Med Cutan Ibero Lat Am; 1982; 10(1):31-6. PubMed ID: 6214674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acne-like chronic inflammatory activity of Propionibacterium acnes preparations in an animal model: correlation with ability to stimulate the reticuloendothelial system.
    De Young LM; Spires DA; Ballaron SJ; Cummins CS; Young JM; Allison AC
    J Invest Dermatol; 1985 Sep; 85(3):255-8. PubMed ID: 3161957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In vitro blastogenic response of lymphocytes in acne vulgaris (II) fusing as mitogens isolated from Propionibacterium acnes].
    Vignale RA; Lasalvia E; Paciel J
    Med Cutan Ibero Lat Am; 1977; 5(6):429-31. PubMed ID: 153993
    [No Abstract]   [Full Text] [Related]  

  • 39. [Characteristics of the Propionibacterium strains isolated from acne patients].
    Białecka A; Kasprowicz A; Kaszycki P; Marcinkiewicz J
    Med Dosw Mikrobiol; 2004; 56(1):79-92. PubMed ID: 15524399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Anti-Inflammatory Activities of Propionibacterium acnes CAMP Factor-Targeted Acne Vaccines.
    Wang Y; Hata TR; Tong YL; Kao MS; Zouboulis CC; Gallo RL; Huang CM
    J Invest Dermatol; 2018 Nov; 138(11):2355-2364. PubMed ID: 29964032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.